- Healthcare organizations are under growing financial strain due to rising labor costs, coder shortages, and complex payer requirements.
- Most existing coding solutions focus narrowly on reimbursement and fail to address documentation gaps and denial risks.
- Arintra offers a GenAI-native platform that combines autonomous coding, provider-specific clinical documentation improvement (CDI), and payer-aware denial insights.
- This integrated approach helps providers secure full, compliant reimbursement while reducing operational costs and manual effort.
- Arintra has delivered proven enterprise-scale outcomes across large health systems and physician groups.
- With backing from strategic investors—including Endeavor Health Ventures—Arintra is expanding rapidly across the U.S. healthcare market.
National, August 12, 2025 — Arintra, the GenAI-native platform transforming autonomous medical coding into full-spectrum revenue assurance, has announced a $21 million Series A funding round led by Peak XV Partners, with participation from Endeavor Health Ventures, Y Combinator, Counterpart Ventures, Spider Capital, Ten13, and other strategic investors. The funding will accelerate product innovation, expand payer-aware capabilities, and support nationwide deployment across health systems and physician groups. Arintra will also establish a new Bay Area headquarters to fuel its next phase of growth.
Why It Matters
Healthcare providers are under immense financial pressure. Rising labor costs, coder shortages, and increasingly complex payer rules have created a perfect storm. Traditional coding tools focus narrowly on reimbursement, often missing documentation gaps and denial risks. Arintra addresses this by offering end-to-end revenue assurance, not just code assignment.
Arintra’s GenAI-Powered Solution
Arintra unifies three critical pillars in a single, explainable workflow:
- Autonomous Medical Coding: High-accuracy, specialty-aware code assignment with audit trails.
- Clinical Documentation Improvement (CDI): Real-time prompts to close gaps affecting reimbursement and quality metrics.
- Payer-Aware Denial Prevention: Insights based on plan-specific policies and historical denial data to reduce rework and appeals.
“We help providers document precisely, code correctly, and submit defensible claims—enabling full, compliant reimbursement with less manual effort,” said Preeti Bhargava, Co-founder & CTO.
Proven Impact at Scale
Arintra has processed over $1 billion in healthcare charges, delivering measurable ROI:
- Mercyhealth: 5.1% revenue uplift, 43% fewer denials, 50% reduction in work queue aging, 32% lower coding costs.
- Reid Health: Faster A/R and improved coding accuracy via deep Epic integration.
“Arintra changed how we code without disrupting workflows. It’s one of the few AI tools that delivers hard ROI, fast,” said Muhammad Siddiqui, CIO, Reid Health.
Founder Vision
Arintra was born from a personal experience with a surprise medical bill caused by a coding error. Founders Nitesh Shroff (CEO) and Preeti Bhargava (CTO), both computer science PhDs, built Arintra to fix the broken reimbursement system using GenAI and clinical intelligence.
“Reimbursement in healthcare is fundamentally broken. Payers are shifting more burden onto providers, but legacy tools haven’t kept up. Arintra secures compliant revenue at scale,” said Nitesh Shroff, Co-founder & CEO.
Investor Perspective
“Arintra is vertical AI done right—real adoption, clear ROI, and a strong roadmap,” said Mohit Bhatnagar, MD, Peak XV Partners. “It’s tackling one of healthcare’s hardest problems: translating clinical documentation into accurate, defensible codes.”
How Arintra Works
- GenAI + Clinical Knowledge Graphs: Specialty-specific logic for precision coding.
- Explainable Outputs: Every code includes rationale and traceability.
- Native EHR Integration: Seamless operation within Epic, athenahealth, and others.
- Payer-Aware Intelligence: Prevents denials by accounting for policy nuances.
- Enterprise-Grade Security: Fully compliant with U.S. healthcare standards.
What’s Next
With Series A funding, Arintra will:
- Expand across inpatient and ambulatory specialties
- Advance denial prevention and CDI capabilities
- Deepen analytics for revenue cycle leaders
- Scale deployment and customer success teams
About Arintra
Arintra is the leading GenAI-native platform for autonomous coding and revenue assurance. It helps healthcare providers get paid accurately and efficiently by integrating coding, documentation, and denial prevention into one seamless system. Trusted by top health systems, Arintra delivers measurable improvements in revenue, compliance, and operational efficiency.
Documented Outcomes:
- 5%+ uplift in net revenue
- 12%+ reduction in A/R days
- 43%+ fewer denials
- 30%+ lower coding costs
Actual results vary by specialty mix, payer mix, and deployment scope.
